welcome to DuchenneXchange- a positively charged Duchenne muscular dystrophy community.
- join today!
A Registered Cohort Study on Duchenne Muscular Dystrophy
study id #: NCT04012671
condition: Duchenne Muscular Dystrophy
Dystrophinopathy is a term of X-linked recessive genetic disease, including Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and the X-linked dilated cardiomyopathy. The aim of this study is to determine the clinical spectrum and natural progression of dystrophinopathy in a prospective multicenter natural history study, to assess the clinical, genetic of patients with dystrophinopathy to optimize clinical management.
last updated: October 05, 2019
start date: July 1, 2019
estimated completion: December 31, 2039
phase of development: N/A
size / enrollment: 2000
- Age at death [ Time Frame: 20 years ]
The time when patient die
• Beyond 2 years old
• Diagnosis with Duchenne Muscular Dystrophy, and female carriers, genotypically confirmed
• Diagnosis should be supported by muscle biopsy, if no genetic confirmation.
• Presence of other clinically significant illness
other Duchenne content
Tim Lotze, MDDr. Tim Lotze is a specialized neurologi...
Extension Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD)This is an open-label, extension study o...
Rosaline Quinlivan, BSc (Hons), MBBS, DCH, FRCPCH, FRCP, MDDr. Rosaline Quinlivan is the clinical ...
Hope in Translation: Bringing Gene Therapy to the ClinicIn 1987, scientists first uncovered the ...
Jeffrey S. Chamberlain, PhDDr. Jeffrey Chamberlain is a neurologist...
Diagnosed with Duchenne – Embracing Life Beyond the DevastationThe Beautiful Blessings of Motherhood I...
Plus Epicatechin Duchenne Muscular Dystrophy in Non-ambulatory AdolescentsThis single center open-label pilot stud...